Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

How We Got Here: Baxalta And Shire Reach Final Merger Hurdle

This article was originally published in Scrip

Executive Summary

Following Baxalta Inc.'s announcement that it will hold a special meeting of stockholders on May 27 for investors to cast the final vote on its merger agreement with specialty biopharma company Shire, Scrip has taken a look back over the last year to see how this $32bn deal got made.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC064981

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel